Literature DB >> 27557521

Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.

Fuling Zhou1,2, Ming Li1, Yongchang Wei1,3, Kevin Lin4, Yue Lu4, Jianjun Shen4, Gary L Johanning1, Feng Wang-Johanning1.   

Abstract

Human endogenous retrovirus type K (HERV-K) Env protein was previously demonstrated to be overexpressed in human breast cancer (BC) cells and tissues. However, the molecular pathways driving the specific alterations are unknown. We now show that knockdown of its expression with an shRNA (shRNAenv) blocked BC cell proliferation, migration, and invasion. shRNAenv transduction also attenuated the ability of BC cells to form tumors, and notably prevented metastasis. Mechanistically, downregulation of HERV-K blocked expression of tumor-associated genes that included Ras, p-RSK, and p-ERK. The major upstream regulators influenced by HERV-K knockdown were p53, TGF- β1, and MYC. Of interest, when the HERV-K env gene was overexpressed in shRNAenv-transduced BC cells using an HERV-K env expression vector, Ras/Raf/MEK/ERK pathway signaling was restored. CDK5, which alters p53 phosphorylation in some cancers, was upregulated and p53 was downregulated when HERV-K was overexpressed. CDK5 is also a mediator of TGF-β1-induced epithelial-mesenchymal transition and migration in cancer cells, and is involved in tumor formation. Importantly, reductions in migration, invasion, and transformation of BC cells stably transduced with shRNAenv was reversed after adding back a vector with a synonymous mutation of HERV-K env. Taken together, these results indicate that HERV-K Env protein plays an important role in tumorigenesis and metastasis of BC.

Entities:  

Keywords:  HERV-K; Ras signaling; breast cancer; shRNA; tumorigenesis and metastasis

Mesh:

Substances:

Year:  2016        PMID: 27557521      PMCID: PMC5356647          DOI: 10.18632/oncotarget.11455

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  35 in total

1.  Evolutionary analyses of the human genome.

Authors:  W H Li; Z Gu; H Wang; A Nekrutenko
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

3.  Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Authors:  Jing Zhao; Kiera Rycaj; Shanshan Geng; Ming Li; Joshua B Plummer; Bingnan Yin; Hong Liu; Xu Xu; Yinchun Zhang; Yanfang Yan; Sharon A Glynn; Tiffany H Dorsey; Stefan Ambs; Gary L Johanning; Lin Gu; Feng Wang-Johanning
Journal:  Genes Cancer       Date:  2011-09

4.  Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.

Authors:  Feng Wang-Johanning; Jinsong Liu; Kiera Rycaj; Miao Huang; Kate Tsai; Daniel G Rosen; Dung-Tsa Chen; Danielle W Lu; Kirstin F Barnhart; Gary L Johanning
Journal:  Int J Cancer       Date:  2007-01-01       Impact factor: 7.396

5.  Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.

Authors:  Shuang Li; Qingzhu Wei; Qin Li; Bin Zhang; Qiang Xiao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.

Authors:  Kiera Rycaj; Joshua B Plummer; Bingnan Yin; Ming Li; Jeremy Garza; Laszlo Radvanyi; Lois M Ramondetta; Kevin Lin; Gary L Johanning; Dean G Tang; Feng Wang-Johanning
Journal:  Clin Cancer Res       Date:  2014-11-04       Impact factor: 12.531

7.  Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways.

Authors:  Jian Wang; Yanzhi Yuan; Ying Zhou; Longhua Guo; Lingqiang Zhang; Xuezhang Kuai; Binwei Deng; Zhi Pan; Dong Li; Fuchu He
Journal:  J Proteome Res       Date:  2008-07-15       Impact factor: 4.466

8.  Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.

Authors:  Feng Wang-Johanning; Ming Li; Francisco J Esteva; Kenneth R Hess; Bingnan Yin; Kiera Rycaj; Joshua B Plummer; Jeremy G Garza; Stefan Ambs; Gary L Johanning
Journal:  Int J Cancer       Date:  2013-09-13       Impact factor: 7.396

9.  Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Authors:  Maya Golan; Amnon Hizi; James H Resau; Neora Yaal-Hahoshen; Hadar Reichman; Iafa Keydar; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

10.  Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.

Authors:  Fuling Zhou; Janani Krishnamurthy; Yongchang Wei; Ming Li; Kelly Hunt; Gary L Johanning; Laurence Jn Cooper; Feng Wang-Johanning
Journal:  Oncoimmunology       Date:  2015-05-26       Impact factor: 8.110

View more
  46 in total

1.  The Oldest Co-opted gag Gene of a Human Endogenous Retrovirus Shows Placenta-Specific Expression and Is Upregulated in Diffuse Large B-Cell Lymphomas.

Authors:  Guney Boso; Katherine Fleck; Samuel Carley; Qingping Liu; Alicia Buckler-White; Christine A Kozak
Journal:  Mol Biol Evol       Date:  2021-12-09       Impact factor: 8.800

Review 2.  Human endogenous retrovirus regulates the initiation and progression of cancers (Review).

Authors:  Srishti Sahu; Bharat Singh; Ambak Kumar Rai
Journal:  Mol Clin Oncol       Date:  2022-08-03

3.  Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.

Authors:  Ming Li; Laszlo Radvanyi; Bingnan Yin; Kiera Rycaj; Jia Li; Raghavender Chivukula; Kevin Lin; Yue Lu; JianJun Shen; David Z Chang; Donghui Li; Gary L Johanning; Feng Wang-Johanning
Journal:  Clin Cancer Res       Date:  2017-07-05       Impact factor: 12.531

Review 4.  Ancient Adversary - HERV-K (HML-2) in Cancer.

Authors:  Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Faizan H Khan; Sharon A Glynn
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 5.  Endogenous retroviruses in the origins and treatment of cancer.

Authors:  Natasha Jansz; Geoffrey J Faulkner
Journal:  Genome Biol       Date:  2021-05-10       Impact factor: 13.583

6.  Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology.

Authors:  David F Grabski; Yinin Hu; Monika Sharma; Sara K Rasmussen
Journal:  J Surg Res       Date:  2019-03-29       Impact factor: 2.417

7.  Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma.

Authors:  Weijie Ma; Zhenfei Hong; Hailing Liu; Xi Chen; Lu Ding; Zhisu Liu; Fuling Zhou; Yufeng Yuan
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

8.  HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.

Authors:  Ayele Argaw-Denboba; Emanuela Balestrieri; Annalucia Serafino; Chiara Cipriani; Ilaria Bucci; Roberta Sorrentino; Ilaria Sciamanna; Alessandra Gambacurta; Paola Sinibaldi-Vallebona; Claudia Matteucci
Journal:  J Exp Clin Cancer Res       Date:  2017-01-26

9.  Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells.

Authors:  David Díaz-Carballo; Jacqueline Klein; Ali H Acikelli; Camilla Wilk; Sahitya Saka; Holger Jastrow; Gunther Wennemuth; Phillip Dammann; Urs Giger-Pabst; Veria Khosrawipour; Joachim Rassow; Mikalai Nienen; Dirk Strumberg
Journal:  Oncotarget       Date:  2017-10-07

10.  SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression.

Authors:  Tara T Doucet-O'Hare; Brianna L DiSanza; Catherine DeMarino; Abigail L Atkinson; Jared S Rosenblum; Lisa J Henderson; Kory R Johnson; Jeffrey Kowalak; Marta Garcia-Montojo; Sariah J Allen; Brent A Orr; Mariarita Santi; Tongguang Wang; Saeed Fathi; Myoung Hwa Lee; Kevon Sampson; Wenxue Li; Zhengping Zhuang; Avindra Nath
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.